Eric Baumann, a healthy 34-year-old, in love with life and his new girlfriend, had just started as the new London correspondent for the Swiss daily Tages-Anzeiger when he was diagnosed with brain cancer. His description, [more]
Efforts to improve the care of Europe’s leukaemia patients have been boosted by a highly motivated, well-focused network that is integrating thework of trial groups and partner groups, involving diagnostics, treatment, registries and guidelines. Download [more]
Cisplatin-based chemoradiation has been shown to be superior to radiotherapy plus hydroxyurea for stage IB to III cervical cancer, conferring better survival rates withmodest long-term toxicity. Download full article
A retrospective study has shown that haematopoietic stem cell rescue in tandem with high-dose chemotherapy should be considered a major treatment option in patients with testicular cancer following first-salvage chemotherapy and/or in cisplatin-refractory disease. Download [more]
Selected reports edited by Janet Fricker Download full article
Despite an EU directive out lawing job discrimination, cancer patients are still routinely forced out of work by employers who don’t want themor refuse to accommodate their need for lighter work or a shorter working [more]
In early March the International Narcotics Control Board (INCB), a UN agency, issued its annual report highlighting yet again the plight of millions of people around the world who continue to suffer acute [more]
Ulrik Ringborg remembers a time before pressure on cancer services led Sweden to abandon a model that combined clinical and research responsibilities. He believes comprehensive cancer centres, similar to those in the US, are key [more]
Europe has money, human resources and a basic-science base that produces world-leading cancer research. Why, then, aren’t these assets being translated into clinical advances? Download full article
Cancer research is being held back by a shortage of high-quality, well-documented biological specimens. However, convincing hospitals to pool their specimens in a regional, national or international biobank is not always easy, adding to the [more]
Silvio Garattini gave up a glittering academic career to found his own set-up where research could be carried out free from commercial or political agendas. Today, the Mario Negri Institute and its founder play a [more]